Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective
Frontiers | Progress in the Research and Development of Anti-COVID-19 Drugs
Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum
Antiviral drugs proposed for COVID-19: action mechanism and pharmacological data
Emerging pharmacotherapies for COVID-19 - ScienceDirect
Frontiers | Mechanism of Action of Small-Molecule Agents in Ongoing Clinical Trials for SARS-CoV-2: A Review
HIV protease inhibitors and nuclear lamin processing: Getting the right bells and whistles | PNAS
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
How Ritonavir acts as booster drug - YouTube
Biomolecules | Free Full-Text | SARS-CoV-2 Mpro: A Potential Target for Peptidomimetics and Small-Molecule Inhibitors
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial - The Lancet
Infectious diseases | Nature Reviews Drug Discovery
Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019 | Journal of the American Heart Association
Oral antiviral treatments for COVID-19: opportunities and challenges | SpringerLink
SARS-CoV-2 antivirals ~ ViralZone
Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials | Bentham Science
Frontiers | Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives
JKMS :: Journal of Korean Medical Science
Therapeutic advances in COVID-19 | Nature Reviews Nephrology
Experimental COVID-19 Therapy Combination Lopinavir/Ritonavir Is Implicated in a Complicated Set of Drug-Drug Interactions - Anesthesia Patient Safety Foundation
Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum
Research Highlight: Derivatization and Combination Therapy of COVID-19 Therapeutic agents | LAU News
HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor‐Dependent Increases in NADPH Oxidase 1 (Nox1), C‐C Chemokine Receptor Type 5 (CCR5), and Inflammation | Journal
Drug repurposing approach to fight COVID-19 | SpringerLink
Epidemic and pandemic viral infections: impact on tuberculosis and the lung | European Respiratory Society
Life | Free Full-Text | Statins in COVID-19 Therapy
Why Are Lopinavir and Ritonavir Effective against the Newly Emerged Coronavirus 2019? Atomistic Insights into the Inhibitory Mechanisms | Biochemistry
